Why Now Is the Right Time to Invest in Your First Drug Safety System
Small and emerging biopharma like yours face a crucial question ...
Small and emerging biopharma like yours face a crucial question ...
Sam Wallis, Head of ICSR Case Processing within the Worldwide Patient Safety Operations at Bristol Myers Squibb, will join a Breakthrough 2024 panel discussion on the reality of transitioning Safety/Regulatory systems to the cloud. Here, he provides a glimpse into BMS’s own journey, which he’ll share candidly during the Day 1 debate.
There’s no doubt that the pharmaceutical industry is well into ...
The coronavirus pandemic ushered in a new era of public ...
Organizations currently utilizing manual pharmacovigilance processing understand that it involves many time-consuming manual activities, but ArisGlobal’s LifeSphere Multivigilance 10 is the future of pharmacovigilance.
The Future of Drug Safety Intelligence The future of safety ...
As part of our commitment to providing the most robust ...
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
Advanced computing methods can be used for safety monitoring and early detection of potential signals of vaccine-related adverse events. These methods work by mining open-access active-moiety databases and vast scientific literature with clinical case studies.
On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”. In this webinar, we posed a few questions to the audience, and came up with some interesting information. We took this and spent some thinking about what this means to our clients in the PV ecosystem.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved